• Aggarwal M, Sharma R, Kumar P, Parida M, Tomar S (2015) Kinetic characterization of trans-proteolytic activity of Chikungunya virus capsid protease and development of a FRET-based HTS assay. Sci Rep 5:14753

  • Amarilla AA, Sng JDJ, Parry R, Deerain JM, Potter JR, Setoh YX, Rawle DJ, Le TT, Modhiran N, Wang X, Peng NYG, Torres FJ, Pyke A, Harrison JJ, Freney ME, Liang B, McMillan CLD, Cheung STM, Guevara D, Hardy JM, Bettington M, Muller DA, Coulibaly F, Moore F, Hall RA, Young PR, Mackenzie JM, Hobson-Peters J, Suhrbier A, Watterson D, Khromykh AA (2021) A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses. Nat Commun 12:3431

  • Amaya M, Cheng H, Borisevich V, Navaratnarajah CK, Cattaneo R, Cooper L, Moore TW, Gaisina IN, Geisbert TW, Rong L, Broder CC (2021) A recombinant Cedar virus based high-throughput screening assay for henipavirus antiviral discovery. Antiviral Res 193:105084

  • Azar SR, Campos RK, Bergren NA, Camargos VN, Rossi SL (2020) Epidemic Alphaviruses:Ecology, Emergence and Outbreaks. Microorganisms 8:1167

  • Bai X, Sun H, Wu S, Li Y, Wang L, Hong B (2022) Identifying Small-Molecule Inhibitors of SARS-CoV-2 RNA-Dependent RNA Polymerase by Establishing a Fluorometric Assay. Front Immunol 13:844749

  • Briolant S, Garin D, Scaramozzino N, Jouan A, Crance JM (2004) In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds:synergistic effect of interferon-alpha and ribavirin combination. Antiviral Res 61:111-117

  • Bullard-Feibelman KM, Fuller BP, Geiss BJ (2016) A Sensitive and Robust High-Throughput Screening Assay for Inhibitors of the Chikungunya Virus nsP1 Capping Enzyme. PLoS One 11:e0158923

  • Clark LE, Clark SA, Lin C, Liu J, Coscia A, Nabel KG, Yang P, Neel DV, Lee H, Brusic V, Stryapunina I, Plante KS, Ahmed AA, Catteruccia F, Young-Pearse TL, Chiu IM, Llopis PM, Weaver SC, Abraham J (2022) VLDLR and ApoER2 are receptors for multiple alphaviruses. Nature 602:475-480

  • Creanga A, Gillespie RA, Fisher BE, Andrews SF, Lederhofer J, Yap C, Hatch L, Stephens T, Tsybovsky Y, Crank MC, Ledgerwood JE, McDermott AB, Mascola JR, Graham BS, Kanekiyo M (2021) A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodies. Nat Commun 12:1722

  • Deng CL, Liu SQ, Zhou DG, Xu LL, Li XD, Zhang PT, Li PH, Ye HQ, Wei HP, Yuan ZM, Qin CF, Zhang B (2016a) Development of Neutralization Assay Using an eGFP Chikungunya Virus. Viruses 8

  • Deng CL, Liu SQ, Zhou DG, Xu LL, Li XD, Zhang PT, Li PH, Ye HQ, Wei HP, Yuan ZM, Qin CF, Zhang B (2016b) Development of Neutralization Assay Using an eGFP Chikungunya Virus. Viruses 8:181

  • Fazakerley JK (2002) Pathogenesis of Semliki Forest virus encephalitis. J Neurovirol 8 Suppl 2:66-74

  • Fernandes RS, Freire M, Bueno RV, Godoy AS, Gil L, Oliva G (2020) Reporter Replicons for Antiviral Drug Discovery against Positive Single-Stranded RNA Viruses. Viruses 12:598

  • Huang YH, Huang JT (2021) Use of chlorhexidine to eradicate oropharyngeal SARS-CoV-2 in COVID-19 patients. J Med Virol 93:4370-4373

  • Huffman JH, Sidwell RW, Khare GP, Witkowski JT, Allen LB, Robins RK (1973) In vitro effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid viruses. Antimicrob Agents Chemother 3:235-241

  • Johnston PA, Phillips J, Shun TY, Shinde S, Lazo JS, Huryn DM, Myers MC, Ratnikov BI, Smith JW, Su Y, Dahl R, Cosford ND, Shiryaev SA, Strongin AY (2007) HTS identifies novel and specific uncompetitive inhibitors of the two-component NS2B-NS3 proteinase of West Nile virus. Assay Drug Dev Technol 5:737-750

  • Joubert PE, Stapleford K, Guivel-Benhassine F, Vignuzzi M, Schwartz O, Albert ML (2015) Inhibition of mTORC1 Enhances the Translation of Chikungunya Proteins via the Activation of the MnK/eIF4E Pathway. PLoS Pathog 11:e1005091

  • Khan M, Santhosh SR, Tiwari M, Lakshmana Rao PV, Parida M (2010) Assessment of in vitro prophylactic and therapeutic efficacy of chloroquine against Chikungunya virus in vero cells. J Med Virol 82:817-824

  • Lello LS, Utt A, Bartholomeeusen K, Wang S, Rausalu K, Kendall C, Coppens S, Fragkoudis R, Tuplin A, Alphey L, Arien KK, Merits A (2020) Cross-utilisation of template RNAs by alphavirus replicases. PLoS Pathog 16:e1008825

  • Li X, Zhang H, Zhang Y, Li J, Wang Z, Deng C, Jardim ACG, Terzian ACB, Nogueira ML, Zhang B (2019) Development of a rapid antiviral screening assay based on eGFP reporter virus of Mayaro virus. Antiviral Res 168:82-90

  • Liljestrom P, Lusa S, Huylebroeck D, Garoff H (1991) In vitro mutagenesis of a full-length cDNA clone of Semliki Forest virus:the small 6,000-molecular-weight membrane protein modulates virus release. J Virol 65:4107-4113

  • Lundberg L, Brahms A, Hooper I, Carey B, Lin SC, Dahal B, Narayanan A, Kehn-Hall K (2018) Repurposed FDA-Approved drug sorafenib reduces replication of Venezuelan equine encephalitis virus and other alphaviruses. Antiviral Res 157:57-67

  • Lundstrom K (2014) Alphavirus-based vaccines. Viruses 6:2392-2415

  • Lundstrom K (2020) Semliki Forest virus-based immunotherapy for cancer. Expert Opin Biol Ther 20:593-599

  • Maheshwari RK, Husain MM, Attallah AM, Friedman RM (1983) Tunicamycin treatment inhibits the antiviral activity of interferon in mice. Infect Immun 41:61-66

  • Manzano M, Padia J, Padmanabhan R (2014) Small molecule inhibitor discovery for dengue virus protease using high-throughput screening. Methods Mol Biol 1138:331-344

  • Mohankumar V, Dhanushkodi NR, Raju R (2011) Sindbis virus replication, is insensitive to rapamycin and torin1, and suppresses Akt/mTOR pathway late during infection in HEK cells. Biochem Biophys Res Commun 406:262-267

  • Perez L, Irurzun A, Carrasco L (1993) Activation of phospholipase activity during Semliki Forest virus infection. Virology 194:28-36

  • Pohjala L, Barai V, Azhayev A, Lapinjoki S, Ahola T (2008) A luciferase-based screening method for inhibitors of alphavirus replication applied to nucleoside analogues. Antiviral Res 78:215-222

  • Reichert E, Clase A, Bacetty A, Larsen J (2009) Alphavirus antiviral drug development:scientific gap analysis and prospective research areas. Biosecur Bioterror 7:413-427

  • Rothan HA, Bahrani H, Mohamed Z, Teoh TC, Shankar EM, Rahman NA, Yusof R (2015) A combination of doxycycline and ribavirin alleviated chikungunya infection. PLoS One 10:e0126360

  • Rothan HA, Teoh TC (2021) Cell-Based High-Throughput Screening Protocol for Discovering Antiviral Inhibitors Against SARS-COV-2 Main Protease (3CLpro). Mol Biotechnol 63:240-248

  • Roy CJ, Reed DS, Hutt JA (2010) Aerobiology and inhalation exposure to biological select agents and toxins. Vet Pathol 47:779-789

  • Saha A, Acharya BN, Priya R, Tripathi NK, Shrivastava A, Rao MK, Kesari P, Narwal M, Tomar S, Bhagyawant SS, Parida M, Dash PK (2018) Development of nsP2 protease based cell free high throughput screening assay for evaluation of inhibitors against emerging Chikungunya virus. Sci Rep 8:10831

  • Shen L, Niu J, Wang C, Huang B, Wang W, Zhu N, Deng Y, Wang H, Ye F, Cen S, Tan W (2019) High-Throughput Screening and Identification of Potent Broad-Spectrum Inhibitors of Coronaviruses. J Virol 93:e00023-00019

  • Shin G, Yost SA, Miller MT, Elrod EJ, Grakoui A, Marcotrigiano J (2012) Structural and functional insights into alphavirus polyprotein processing and pathogenesis. Proc Natl Acad Sci U S A 109:16534-16539

  • Smee DF, Morris JL, Barnard DL, Van Aerschot A (1992) Selective inhibition of arthropod-borne and arenaviruses in vitro by 3'-fluoro-3'-deoxyadenosine. Antiviral Res 18:151-162

  • Steinberg M (2007) Dasatinib:a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia. Clin Ther 29:2289-2308

  • Su CY, Cheng TJ, Lin MI, Wang SY, Huang WI, Lin-Chu SY, Chen YH, Wu CY, Lai MM, Cheng WC, Wu YT, Tsai MD, Cheng YS, Wong CH (2010) High-throughput identification of compounds targeting influenza RNA-dependent RNA polymerase activity. Proc Natl Acad Sci U S A 107:19151-19156

  • Tamberg N, Lulla V, Fragkoudis R, Lulla A, Fazakerley JK, Merits A (2007) Insertion of EGFP into the replicase gene of Semliki Forest virus results in a novel, genetically stable marker virus. J Gen Virol 88:1225-1230

  • Tarbatt CJ, Glasgow GM, Mooney DA, Sheahan BJ, Atkins GJ (1997) Sequence analysis of the avirulent, demyelinating A7 strain of Semliki Forest virus. J Gen Virol 78 (Pt 7):1551-1557

  • Teppor M, Zusinaite E, Karo-Astover L, Omler A, Rausalu K, Lulla V, Lulla A, Merits A (2021) Semliki Forest Virus Chimeras with Functional Replicase Modules from Related Alphaviruses Survive by Adaptive Mutations in Functionally Important Hot Spots. J Virol 95:e0097321

  • Van Aerschot A, Herdewijn P, Janssen G, Cools M, De Clercq E (1989) Synthesis and antiviral activity evaluation of 3'-fluoro-3'-deoxyribonucleosides:broad-spectrum antiviral activity of 3'-fluoro-3'-deoxyadenosine. Antiviral Res 12:133-150

  • Weisshaar M, Cox R, Morehouse Z, Kumar Kyasa S, Yan D, Oberacker P, Mao S, Golden JE, Lowen AC, Natchus MG, Plemper RK (2016) Identification and Characterization of Influenza Virus Entry Inhibitors through Dual Myxovirus High-Throughput Screening. J Virol 90:7368-7387

  • Xiang Q, Li L, Wu J, Tian M, Fu Y (2022) Application of pseudovirus system in the development of vaccine, antiviral-drugs, and neutralizing antibodies. Microbiol Res 258:126993

  • Xie X, Muruato A, Lokugamage KG, Narayanan K, Zhang X, Zou J, Liu J, Schindewolf C, Bopp NE, Aguilar PV, Plante KS, Weaver SC, Makino S, LeDuc JW, Menachery VD, Shi PY (2020) An Infectious cDNA Clone of SARS-CoV-2. Cell Host Microbe 27:841-848 e843

  • Zhang JH, Chung TD, Oldenburg KR (1999) A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen 4:67-73

  • Zhang JW, Wang H, Liu J, Ma L, Hua RH, Bu ZG (2021) Generation of A Stable GFP-reporter Zika Virus System for High-throughput Screening of Zika Virus Inhibitors. Virol Sin 36:476-489

  • Zhang YN, Zhang QY, Li XD, Xiong J, Xiao SQ, Wang Z, Zhang ZR, Deng CL, Yang XL, Wei HP, Yuan ZM, Ye HQ, Zhang B (2020) Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture. Emerg Microbes Infect 9:1170-1173

  • Zhang ZR, Zhang HQ, Li XD, Deng CL, Wang Z, Li JQ, Li N, Zhang QY, Zhang HL, Zhang B, Ye HQ (2020a) Generation and characterization of Japanese encephalitis virus expressing GFP reporter gene for high throughput drug screening. Antiviral Res 182:104884

  • Zhang ZR, Zhang YN, Li XD, Zhang HQ, Xiao SQ, Deng F, Yuan ZM, Ye HQ, Zhang B (2020b) A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2. Signal Transduct Target Ther 5:218

  • Zou G, Xu HY, Qing M, Wang QY, Shi PY (2011) Development and characterization of a stable luciferase dengue virus for high-throughput screening. Antiviral Res 91:11-19